BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29958195)

  • 81. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 82. How much can screening reduce colorectal cancer mortality in Japan? Scenario-based estimation by microsimulation.
    Kamo KI; Fukui K; Ito Y; Nakayama T; Katanoda K
    Jpn J Clin Oncol; 2022 Mar; 52(3):221-226. PubMed ID: 34897471
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The short to medium term benefits of the Australian colorectal cancer screening program.
    Taylor S; Salimi F; Earnest A; Heriot AG; Zalcberg JR; Ahern S
    Med J Aust; 2021 Feb; 214(2):90-92. PubMed ID: 33230836
    [No Abstract]   [Full Text] [Related]  

  • 84. Deciphering the increasing incidence, special characteristics and possible aetiology of early onset colorectal cancer: A European perspective within an international effort.
    Perea J; Balaguer F
    United European Gastroenterol J; 2020 Mar; 8(2):131-132. PubMed ID: 32213064
    [No Abstract]   [Full Text] [Related]  

  • 85. Improving on-time colorectal cancer screening through lead time messaging.
    Jones WF; Ahnen DJ; Schroy PC
    Cancer; 2020 Jan; 126(2):247-252. PubMed ID: 31568559
    [No Abstract]   [Full Text] [Related]  

  • 86. Colorectal cancer trends in Chile: A Latin-American country with marked socioeconomic inequities.
    Mondschein S; Subiabre F; Yankovic N; Estay C; Von Mühlenbrock C; Berger Z
    PLoS One; 2022; 17(11):e0271929. PubMed ID: 36355864
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The present situation of colorectal cancer in Chile].
    Ríos JA; Barake MF; Arce MJ; López-Köstner F; Labbe TP; Villena J; Becerra S
    Rev Med Chil; 2020 Jun; 148(6):858-867. PubMed ID: 33480387
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of colonic neoplasia detection rates in patients screened inside and outside the National Bowel Cancer Screening Program.
    Whitcher S; Magnusson M; Gani J; Oldmeadow C; Pockney PG
    Med J Aust; 2020 Apr; 212(6):275-276. PubMed ID: 32058586
    [No Abstract]   [Full Text] [Related]  

  • 89. Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy.
    Yoshida N; Maeda-Minami A; Ishikawa H; Mutoh M; Tomita Y; Kobayashi R; Hashimoto H; Inoue K; Hirose R; Dohi O; Itoh Y; Mano Y
    J Gastroenterol; 2024 Jun; 59(6):457-467. PubMed ID: 38466371
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Detection of Colorectal Adenocarcinoma and Grading Dysplasia on Histopathologic Slides Using Deep Learning.
    Kim J; Tomita N; Suriawinata AA; Hassanpour S
    Am J Pathol; 2023 Mar; 193(3):332-340. PubMed ID: 36563748
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients.
    Suzuki N; Price AB; Talbot IC; Wakasa K; Arakawa T; Ishiguro S; Fraser C; Saunders BP
    Scand J Gastroenterol; 2006 Jul; 41(7):812-9. PubMed ID: 16785194
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions.
    Vieth M; Quirke P; Lambert R; von Karsa L; Risio M
    Virchows Arch; 2011 Jan; 458(1):21-30. PubMed ID: 21061132
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Portrayal of cancer prevalence and mortality in Chilean digital media].
    Carrasco-García MA; Neira-Mellado C; Klett B; Cárcamo-Ulloa L
    Rev Med Chil; 2021 May; 149(5):716-723. PubMed ID: 34751324
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The current situation for gastric cancer in Chile.
    Caglevic C; Silva S; Mahave M; Rolfo C; Gallardo J
    Ecancermedicalscience; 2016; 10():707. PubMed ID: 28105078
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Regional cancer incidence among beneficiaries of a private oncological insurance program in Chile].
    Villalobos C; Ferrer-Rosende P; Cavallera C; Cavada G; Manríquez M; Quirland C; Caglevic C; Sapunar J
    Rev Med Chil; 2023 Mar; 151(3):340-348. PubMed ID: 38293879
    [No Abstract]   [Full Text] [Related]  

  • 96. Introduction to the special issue Collaboration between US and Japan for the Early Detection of Cancer.
    Cancer Biomark; 2022; 33(4):425-426. PubMed ID: 35367959
    [No Abstract]   [Full Text] [Related]  

  • 97. Histopathologic study from a colorectal cancer screening in Chile: results from the first 2 years of an international collaboration between Chile and Japan.
    Kobayashi M; Kawachi H; Pasternak S; Delgado C; Pinto P; Ito T; Karelovic S; Carrasco H; Tanaka K; Okada T; Odagaki T; Zárate AJ; Ponce A; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Eur J Cancer Prev; 2019 Jul; 28(4):245-253. PubMed ID: 29958195
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A Pilot Trial to Quantify Plasma Exosomes in Colorectal Cancer Screening from the International Collaborative Study between Chile and Japan.
    Kobayashi M; Kawachi H; Hurtado C; Wielandt AM; Ponce A; Karelovic S; Pasternak S; Delgado C; Pinto P; Carrasco H; Ito T; Okada T; Tanaka K; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Digestion; 2018; 98(4):270-274. PubMed ID: 30130793
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Colorectal cancer risk factors in asymptomatic Chilean population: a survey of international collaboration between Japan and Chile.
    Okada T; Odagaki T; López-Köstner F; Zárate AJ; Ponce A; Kronberg U; Karelovic S; Flores S; Estela R; Ito T; Yasuno M; Uetake H; Kojima K; Kitagawa M
    Eur J Cancer Prev; 2020 Mar; 29(2):127-133. PubMed ID: 31436751
    [TBL] [Abstract][Full Text] [Related]  

  • 100. International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening.
    Okada T; Tanaka K; Kawachi H; Ito T; Nishikage T; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Karelovic S; Flores S; Estela R; Tsubaki M; Uetake H; Eishi Y; Kawano T
    Cancer; 2016 Jan; 122(1):71-7. PubMed ID: 26445309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.